DNAprint Genomics (DNAG)

[frogdreaming]

bag8ger, That first sentence assumes that you have ever had an idea.

As for;

t must rankle you that while we both agree that the previous licensee (I have to accept Ebo's word of what he heard) could do nothing with it, DNAG can and will do something with it.

What is to rankle?

Whether DNAG can or cannot do anything with EPO remains to be seen, and the prospects look exceedingly dim. The discussion however, is based on the reasons that the previous licensee was unwilling or unable to bring a multi-billion dollar drug to market.

If you would kindly refrain from stepping on the conversation perhaps we can elicit a reasonable response from Virgil, who after all initiated the discussion.

regards,
frog